Medical device maker Hologicannounced in a press release late last week that it agreed with diagnostics maker Immucor to sell its Lifecodes business. Lifecodes, which handles transplant diagnostics, ...

本刊推荐：本研究通过系统分析DQ抗原序列比对，鉴定出未被HLA表位注册库（Epregistry）收录的多态性氨基酸，利用LABScreen和 ...

Recently, Hologic Inc. (HOLX) inked a definitive agreement to divest its LIFECODES business unit to Immucor Inc. to focus more on its core business activities. The divestiture is expected to close ...

Recently, Hologic Inc. (HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument–reagent systems space in the blood transfusion ...

Bedford-based medical device maker Hologic Inc. said it has successfully completed the sale of its Lifecodes business unit to Immucor Inc. Hologic has received $85 million in cash with the opportunity ...

Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced a definitive agreement to acquire the LIFECODES business, which ...